Back to search resultsSummaryRMgm-4582
|
||||||||||
*RMgm-4582| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene disruption, Gene disruption |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 30700216 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Kumar H, Frischknecht F |
| Name Group/Department | Integrative Parasitology, Department of Infectious Diseases |
| Name Institute | University of Heidelberg Medical School |
| City | Heidelberg |
| Country | Germany |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-4582 |
| Principal name | itpase(-);ndh(-) |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | Although the two genes are not essential for blood-stage development, mutant parasites were less virulent with prolonged host survival rates. |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Not different from wild type |
| Sporozoite | Normal oocyst and sporozoite production. Reduced motility of sporozoites. Normal sporozoite infectivity to mice. |
| Liver stage | Not different from wild type |
| Additional remarks phenotype | Mutant/mutation 'We proceeded to generating an itpase(-);ndh(-) double mutant in order to determine whether P. berghei NDH and ITPase could compensate each other’s function in the single knockout lines. To this end we first removed the yFCU-hDHFR marker by negative 5-fluorocytosine selection from the itpase(-) clone (RMgm-4580) and then transfected the ndh deletion plasmid into the selection marker-free itpase(-) mutant; limiting dilution cloning was used to generate an isogenic itpase(-);ndh(-) line. Based on structural features, sanitation enzymes belong to four superfamilies: |
Disrupted: Mutant parasite with a disrupted gene| top of page | |||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0618300 | ||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0720800 | ||||||||||||||||||||||||
| Gene product | Ham1-like protein, putative | ||||||||||||||||||||||||
| Gene product: Alternative name | ITPase | ||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||
| Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||
| Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
| Additional remarks partial/complete disruption | |||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr/yfcu | ||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
| Selection (negative) procedure | 5-fluorocytosine (5-FC) | ||||||||||||||||||||||||
| Additional remarks genetic modification | In order to delete individual P. berghei house-cleaning genes (dUTPase: PBANKA_0921300, ITPase: PBANKA_0618300, Ap4AH: PBANKA_1235300, NDH: PBANKA_1361900), 5’UTR and 3’UTR regions were amplified from genomic DNA of mixed blood stages of P. berghei strain ANKA by polymerase chain reaction (PCR) using Phusion High-Fidelity DNA Polymerase (New England Biolabs, USA; fragments were digested with restriction endonucleases and ligated either side of the human dihydrofolate reductase, or a yeast bifunctional enzyme cytosine deaminase fused to a uridyl phosphoribosyl transferase (hdhfr-yFCU) as selection cassettes. Linearized vectors were transfected into purified schizonts of P. berghei ANKA using standard protocols. We proceeded to generating an itpase(-);ndh(-) double mutant in order to determine whether P. berghei NDH and ITPase could compensate each other’s function in the single knockout lines. To this end we first removed the yFCU-hDHFR marker by negative 5-fluorocytosine selection from the itpase(-) clone (RMgm-4580) and then transfected the ndh deletion plasmid into the selection marker-free itpase(-) mutant; limiting dilution cloning was used to generate an isogenic itpase(-);ndh(-) line. | ||||||||||||||||||||||||
| Additional remarks selection procedure | We proceeded to generating an itpase(-);ndh(-) double mutant in order to determine whether P. berghei NDH and ITPase could compensate each other’s function in the single knockout lines. To this end we first removed the yFCU-hDHFR marker by negative 5-fluorocytosine selection from the itpase(-) clone (RMgm-4580) and then transfected the ndh deletion plasmid into the selection marker-free itpase(-) mutant; limiting dilution cloning was used to generate an isogenic itpase(-);ndh(-) line. | ||||||||||||||||||||||||
|
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||
Disrupted: Mutant parasite with a disrupted gene| top of page | |||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_1361900 | ||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_1349100 | ||||||||||||||||||||||||
| Gene product | nucleoside diphosphate hydrolase, putative | ||||||||||||||||||||||||
| Gene product: Alternative name | NDH | ||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||
| Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||
| Partial or complete disruption of the gene | Complete | ||||||||||||||||||||||||
| Additional remarks partial/complete disruption | |||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | hdhfr | ||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||
| Additional remarks genetic modification | In order to delete individual P. berghei house-cleaning genes (dUTPase: PBANKA_0921300, ITPase: PBANKA_0618300, Ap4AH: PBANKA_1235300, NDH: PBANKA_1361900), 5’UTR and 3’UTR regions were amplified from genomic DNA of mixed blood stages of P. berghei strain ANKA by polymerase chain reaction (PCR) using Phusion High-Fidelity DNA Polymerase (New England Biolabs, USA; fragments were digested with restriction endonucleases and ligated either side of the human dihydrofolate reductase, or a yeast bifunctional enzyme cytosine deaminase fused to a uridyl phosphoribosyl transferase (hdhfr-yFCU) as selection cassettes. Linearized vectors were transfected into purified schizonts of P. berghei ANKA using standard protocols. We proceeded to generating an itpase(-);ndh(-) double mutant in order to determine whether P. berghei NDH and ITPase could compensate each other’s function in the single knockout lines. To this end we first removed the yFCU-hDHFR marker by negative 5-fluorocytosine selection from the itpase(-) clone (RMgm-4580) and then transfected the ndh deletion plasmid into the selection marker-free itpase(-) mutant; limiting dilution cloning was used to generate an isogenic itpase(-);ndh(-) line. | ||||||||||||||||||||||||
| Additional remarks selection procedure | We proceeded to generating an itpase(-);ndh(-) double mutant in order to determine whether P. berghei NDH and ITPase could compensate each other’s function in the single knockout lines. To this end we first removed the yFCU-hDHFR marker by negative 5-fluorocytosine selection from the itpase(-) clone (RMgm-4580) and then transfected the ndh deletion plasmid into the selection marker-free itpase(-) mutant; limiting dilution cloning was used to generate an isogenic itpase(-);ndh(-) line. | ||||||||||||||||||||||||
|
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||